Pfizer Inc. (PFE), Johnson & Johnson (JNJ): The Next Frontier?
Only 19 drugs have ever netted at least $5 billion in annual sales -- and most were at their peak --according to a list compiled by Simon King of Forbes earlier this year.
Posts Tagged ‘NYSE:MRK’
Merck & Co., Inc. (MRK), Novo Nordisk A/S (ADR) (NVO): Who Should You Buy?
Recently, I have focused in on some companies that play a major role in diabetic's lives like mine.
Codexis, Inc. (CDXS): This Biotech Stock Keeps Investors Patiently Waiting
Synthetic biology company and industrial bio-enzyme manufacturer Codexis, Inc. (NASDAQ:CDXS) announced its first-quarter earnings after the market closed Tuesday.
Pfizer Inc. (PFE): Risks, Hesitations & Key Opportunities
Take a look around the pharmaceutical industry and you won't find many companies with market caps exceeding $100 billion (seven by my count).
Bank of America Corp (BAC), MBIA Inc. (MBI): Dow (.DJI) Pauses With 15K In Sights
Stocks were mostly flat today as the S&P 500 hit a new record high at 1617.50, but the Dow Jones Industrial Average (Dow Jones Indices:.DJI) was down slightly by five points, ...
AT&T Inc. (T), Verizon Communications Inc. (VZ), And The Dow (.DJI)’s 5 Highest-Yielding Dividend Stocks
It's no secret that investors have been craving high-yielding dividend stocks over the past five years.
Merck & Co., Inc. (MRK), Novartis AG (ADR) (NVS), Pfizer Inc. (PFE): Six Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part II
The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX): Take a Deep Breath Before This Big FDA Decision
Every Sunday I make it a point to examine a combination of earnings stories or Food and Drug Administration panel reviews or PDUFA decisions in the upcoming week that you can'...
Merck & Co., Inc. (MRK), AVEO Pharmaceuticals, Inc. (AVEO): This Week in Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Merck & Co., Inc. (MRK): Three Promising Treatments for a Surprisingly Common Health Problem
It's that time of year. The sounds of sneezing, coughing, and sniffling can be heard across America. Around 40 million people in the U.S.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): FDA Approves Powerful New Cholesterol Drug
Merck & Co., Inc. (NYSE:MRK) gained Food and Drug Administration approval for its powerful new cholesterol drug Liptruzet, a combination of two already-approved drugs, Pfizer...
Merck & Co., Inc. (MRK) Down, Could’ve Fallen Worse
The problem was the other drugs didn't make up nearly enough of the Singulair loss.
International Business Machines Corp. (IBM), Merck & Co., Inc. (MRK), And Blue Chips with Big Buyback Plans
So far this year, major repurchase programs have been announced by some of Wall Street's largest companies.
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Other Names To Know: A Full Breakdown
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Merck & Co., Inc. (MRK): The Foundations of the Pharmaceutical Industry
Merck & Co., Inc. (NYSE:MRK) took its first steps toward pharmaceutical dominance on April 30, 1953, when it merged with Sharp & Dohme, a pharmaceutical manufacturer.
Merck & Co., Inc. (MRK)’s Issues, Fed Bring Down Dow (.DJI)
Whenever the Federal Reserve meets to discuss monetary policy, the stock market holds its breath as it tries to figure out whether the end to the central bank's massive interventions...
A Game-Changer For Pfizer Inc. (PFE)
The wealth-building power of compound interest will never cease to amaze me.
Merck & Co., Inc. (MRK): Post-Earnings Performance Questions
Merck & Co., Inc. (NYSE:MRK) stock could move up or down this week after the pharmaceutical company reports earnings on Wednesday.
How Will Merck & Co., Inc. (MRK)’s Earnings Fare Tomorrow?
Tomorrow, Merck & Co., Inc. (NYSE:MRK) will release its latest quarterly results.
Merck & Co., Inc. (MRK): Will Dividends Keep Going Strong?
Throughout the years, some of the best performing pharmaceutical industry stocks have had long histories of providing healthy dividends to their stockholders. Merck & Co., Inc...
GlaxoSmithKline plc (GSK), Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Buy These Patent-Cliff Proof Stocks
Patent expiration is one of the major issues faced by pharma companies, which increases the competition from generic medicines and eventually leads to downfall in their sales.
Vertex Pharmaceuticals Incorporated (VRTX) Just Jumped & Could Jump Again
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have appreciated significantly in 2013 so far, and it seems that the trend might continue for the rest of the year.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY): A New Diabetes Duo Emerges
That's the message from today's announcement that Pfizer Inc. (NYSE:PFE) is out-licensing its diabetes drug candidate ertugliflozin to Merck & Co., Inc. (NYSE:MRK).
Verizon Communications Inc. (VZ), Pfizer Inc. (PFE), AT&T Inc. (T): What Makes Dow (.DJI) Dividends So Important
Many investors rely on dividends for the income they need from their portfolios.
Merck & Co., Inc. (MRK): How This Can Eventually Lead To Healthy Returns
In the big pharma sector, it can oftentimes be hit or miss when seeking the next big growth stock.
Merck & Co., Inc. (MRK), General Electric Company (GE) & 6 Dow Stocks That Double Up On The T-Bond’s Yield: Part II
In Part I of this series, we discussed three of the six Dow stocks that currently pay yields at least twice as high as that of a 10-Year U.S. Treasury.
Hedge Fund News: David Shaw, Jim Simons, Netflix, Inc. (NFLX)
Editor's Note: Related Tickers: Netflix, Inc. (NASDAQ:NFLX), Verizon Communications Inc. (NYSE:VZ), Dell Inc.
Merck & Co., Inc. (MRK): One Potential Roadblock For A Stock Runup
If you own Merck & Co., Inc. (NYSE:MRK) stock, you likely enjoyed the past couple of months.
Eli Lilly & Co. (LLY): Will The Big Bets Pay Off?
Tomorrow, Eli Lilly & Co. (NYSE:LLY) will release its latest quarterly results.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK) & More: Drug Stocks on Citi’s Dividend Buy List
Barron's recently posted Citi's updated list of large, financially strong, high-yielding, dividend-paying companies.
Bristol Myers Squibb Co. (BMY): Growing Bigger and Better
Bristol Myers Squibb Co. (NYSE:BMY) has been in the spotlight for its so-called “desired” acquisitions and its size issues, along with patent expiration news.
Intel Corporation (INTC), The Gap Inc. (GPS), Cisco Systems, Inc. (CSCO) Among Five Leading Companies in Employee Relations
Like most investors, you probably aim for the best possible return when picking potential investments.
Merck & Co., Inc. (MRK): It Is Not Worth It
Big pharma companies are massive, complicated beasts.
Johnson & Johnson (JNJ): Three Things You Need to Watch
Earnings season's in full throttle now, and Johnson & Johnson (NYSE:JNJ) stepped up and released its quarterly data Tuesday.
Hedge Fund News: Carl Icahn, John Burbank, AT&T Inc. (T)
Editor's Note: Related Tickers: Microsoft Corporation (NASDAQ:MSFT), SanDisk Corporation (NASDAQ:SNDK), Google Inc (NASDAQ:GOOG), UTStarcom Holdings Corp (NASDAQ:UTSI), AT&T Inc...
Merck & Co., Inc. (MRK)’s Latest Drug and Strategy Concoctions
Merck & Co., Inc. (NYSE:MRK) reported a 7% decline in fourth-quarter profit after the patent expiry of Singulair on August 13, 2012, in the United States.
The Procter & Gamble Company (PG), 3M Co (MMM), Merck & Co., Inc. (MRK), Intel Corporation (INTC) & Three Investment Opportunities for Scared Investors
Plunging markets are always scary, but they also create great investment opportunities for those who are brave enough to reach out for them.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): The US’s Hidden Obesity Epidemic
The United States is the fattest country in the world -- and I'm not talking about our wallets, folks! According to the Centers for Disease Control and Prevention, a disheartening...
Apple Inc. (AAPL), Research In Motion Ltd (BBRY): Who Cares If The Market Had A Bad Week?
Seriously, as a retired broker – and a retired reporter – I had to make this case all the time. Reporting on the markets is terrible.
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK) & More: Three Undeniably Awesome Health Care Dividend Stocks
Looking for solid dividends? The health care sector has plenty of dividend stocks to choose from.
Merck & Co., Inc. (MRK): This Stock Rocked, So What Just Happened to Mine?
Merck & Co., Inc. (NYSE:MRK) stock soared almost 3% Wednesday to close in on a new 52-week high after the pharmaceutical giant announced the FDA accepted its new drug application...
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), and the Dow (.DJI) Hits the Fast Lane Toward 15,000
The Dow Jones Industrial Average jumped again today, riding a wave that carried the S&P 500 up 1.2% and lifted the Nasdaq 1.8%.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE) and Big Pharma Led the Dow Jones Industrial Average (.DJI) to New Highs Today
Investors have been as clear as they can be about what they see as their ideal situation.
Johnson & Johnson (JNJ), Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK): How the Dow (.DJI)’s Pharma Stocks Have Fared in 2013
The Dow Jones Industrial Average isn't just for industrial stocks anymore.
Tackling Cancer With Merck & Co., Inc. (MRK), Endo Health Solutions Inc (ENDP) & More: Bladder Cancer’s Biggest Current and Upcoming Players
As I noted six weeks ago, cancer statistics are both staggering and disappointing.
Merck & Co., Inc. (MRK): Will The FDA Wake Up to Sugammadex’s Potential?
It is easy for biotech investors to get antsy when it comes to approvals from the Food and Drug Administration.
Amgen, Inc. (AMGN), Merck & Co., Inc. (MRK): Can It Field a Psoriasis Blockbuster?
Targeting psoriasis, rheumatoid arthritis, and other immune diseases has created some massive markets over the last decade.
AstraZeneca plc (ADR) (AZN): Hedge Funds are Bearish…What to Do?
Is AstraZeneca plc (ADR) (NYSE:AZN) worth your attention right now? The smart money is becoming less confident. The number of long hedge fund bets fell by 2 lately.
Johnson & Johnson (JNJ): Abbott Laboratories (ABT), Too Cheap to Ignore?
Looking for a cheap stock with name-brand power and a strong, diversified portfolio of products? At first glance, you couldn't do much better than Abbott Laboratories (NYSE:ABT...
